Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zymeworks
Biotech
Zymeworks withholds one ADC from clinic in favor of another
Zymeworks has pumped the brakes on plans to take one of its antibody-drug conjugates into the clinic so it can prioritize another candidate.
James Waldron
Mar 6, 2025 10:25am
ASCO: Jazz shares 'unprecedented' biliary tract cancer data
Jun 1, 2024 11:11am
Zymeworks halts phase 2 ADC plans over 'clinical landscape'
Mar 7, 2024 9:00am
Jazz auditioning for new bandmates in hot M&A market
Jun 6, 2023 9:35am
Gilead taps Roche exec to fly Kite—Chutes & Ladders
May 19, 2023 9:30am
Zymeworks, Daiichi end $293M bispecific collab
Mar 20, 2023 9:15am
